Last reviewed 2026-05-13 · How we verify

Piritramid (analgetic)

Piritramid is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia.

Piritramid is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia. Used for Moderate to severe acute pain, Postoperative pain.

At a glance

Mechanism of action

Piritramid acts as a mu opioid receptor agonist, similar to morphine and other opioids. By binding to mu receptors in the brain and spinal cord, it modulates pain perception and transmission, providing potent analgesia. It is used primarily for moderate to severe acute pain management.

Approved indications

• Moderate to severe acute pain
• Postoperative pain

Common side effects

• Respiratory depression
• Nausea and vomiting
• Dizziness
• Constipation
• Sedation

Key clinical trials

• Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery (NA)
• Observational Study of Analgesia and Cost-efficiency of Analgetic Medication Pumps (Zalviso and PCA-syringe Pump (PCA=Patient Controlled Analgesia)) After Urogenital Intervention at the Clinical Daily Routine
• Comparison of Three Different Pain and Anxiety Reducing Methods in Adult Patients Undergoing Bone Marrow Puncture (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Piritramid (analgetic) CI brief — competitive landscape report
• Piritramid (analgetic) updates RSS · CI watch RSS
• Technische Universität Dresden portfolio CI